Cargando…

Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model

Resveratrol (REV) is a plant polyphenol with a plethora of beneficial properties. We previously enhanced the efficacy of REV via esterification of REV with butyrate to form resveratrol butyrate ester (RBE). Compared with REV, RBE exhibits higher bioavailability and better antioxidant effects. Hypert...

Descripción completa

Detalles Bibliográficos
Autores principales: Tain, You-Lin, Hou, Chih-Yao, Chang-Chien, Guo-Ping, Lin, Sufan, Hsu, Chien-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921909/
https://www.ncbi.nlm.nih.gov/pubmed/36771404
http://dx.doi.org/10.3390/nu15030697
_version_ 1784887425117454336
author Tain, You-Lin
Hou, Chih-Yao
Chang-Chien, Guo-Ping
Lin, Sufan
Hsu, Chien-Ning
author_facet Tain, You-Lin
Hou, Chih-Yao
Chang-Chien, Guo-Ping
Lin, Sufan
Hsu, Chien-Ning
author_sort Tain, You-Lin
collection PubMed
description Resveratrol (REV) is a plant polyphenol with a plethora of beneficial properties. We previously enhanced the efficacy of REV via esterification of REV with butyrate to form resveratrol butyrate ester (RBE). Compared with REV, RBE exhibits higher bioavailability and better antioxidant effects. Hypertension can originate in early life because of maternal toxic chemical exposure. This study aims to examine the effectiveness of RBE in the protection of offspring hypertension induced by maternal di-2-ethylhexylphthalate (DEHP) exposure and to explore the underlying mechanisms. DEHP (10 mg/kg/day) was used as oral gavage to pregnant rats during gestation and lactation. The control group received the vehicle. Three groups of DEHP-exposed dams received REV (6.67 mg/kg/day), or low-dose (3.33 mg/kg/day) or high-dose (6.67 mg/kg/day) RBE in drinking water during gestation and lactation. Perinatal DEHP exposure resulted in hypertension and bodyweight gain in adult male offspring, which was prevented by high-dose RBE. REV supplementation attenuated DEHP exposure-induced increases in blood pressure but not bodyweight. High-dose RBE decreased renal oxidative damage, increased plasma butyrate concentrations, and altered short chain fatty acid receptor (SCFA) expression. Low-dose RBE treatment reduced downstream mediators of the acryl hydrocarbon receptor (AHR) signaling pathway. Moreover, DEHP exposure, REV and RBE treatment differentially shaped the offspring’s gut microbiota. In particular, high-dose RBE increased the abundance of the genus Duncaniella. The beneficial effects of RBE treatment were related to reducing oxidative damage, increasing plasma butyrate concentrations, downregulating SCFA receptor expression, antagonizing AHR signaling, and altering the gut microbiota. This study provides the first evidence of RBE as a novel plant polyphenol bioproduct targeting the oxidative stress and gut microbiota to protect against maternal DEHP exposure-primed offspring hypertension.
format Online
Article
Text
id pubmed-9921909
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99219092023-02-12 Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model Tain, You-Lin Hou, Chih-Yao Chang-Chien, Guo-Ping Lin, Sufan Hsu, Chien-Ning Nutrients Article Resveratrol (REV) is a plant polyphenol with a plethora of beneficial properties. We previously enhanced the efficacy of REV via esterification of REV with butyrate to form resveratrol butyrate ester (RBE). Compared with REV, RBE exhibits higher bioavailability and better antioxidant effects. Hypertension can originate in early life because of maternal toxic chemical exposure. This study aims to examine the effectiveness of RBE in the protection of offspring hypertension induced by maternal di-2-ethylhexylphthalate (DEHP) exposure and to explore the underlying mechanisms. DEHP (10 mg/kg/day) was used as oral gavage to pregnant rats during gestation and lactation. The control group received the vehicle. Three groups of DEHP-exposed dams received REV (6.67 mg/kg/day), or low-dose (3.33 mg/kg/day) or high-dose (6.67 mg/kg/day) RBE in drinking water during gestation and lactation. Perinatal DEHP exposure resulted in hypertension and bodyweight gain in adult male offspring, which was prevented by high-dose RBE. REV supplementation attenuated DEHP exposure-induced increases in blood pressure but not bodyweight. High-dose RBE decreased renal oxidative damage, increased plasma butyrate concentrations, and altered short chain fatty acid receptor (SCFA) expression. Low-dose RBE treatment reduced downstream mediators of the acryl hydrocarbon receptor (AHR) signaling pathway. Moreover, DEHP exposure, REV and RBE treatment differentially shaped the offspring’s gut microbiota. In particular, high-dose RBE increased the abundance of the genus Duncaniella. The beneficial effects of RBE treatment were related to reducing oxidative damage, increasing plasma butyrate concentrations, downregulating SCFA receptor expression, antagonizing AHR signaling, and altering the gut microbiota. This study provides the first evidence of RBE as a novel plant polyphenol bioproduct targeting the oxidative stress and gut microbiota to protect against maternal DEHP exposure-primed offspring hypertension. MDPI 2023-01-30 /pmc/articles/PMC9921909/ /pubmed/36771404 http://dx.doi.org/10.3390/nu15030697 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tain, You-Lin
Hou, Chih-Yao
Chang-Chien, Guo-Ping
Lin, Sufan
Hsu, Chien-Ning
Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title_full Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title_fullStr Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title_full_unstemmed Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title_short Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
title_sort resveratrol butyrate ester supplementation blunts the development of offspring hypertension in a maternal di-2-ethylhexyl phthalate exposure rat model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921909/
https://www.ncbi.nlm.nih.gov/pubmed/36771404
http://dx.doi.org/10.3390/nu15030697
work_keys_str_mv AT tainyoulin resveratrolbutyrateestersupplementationbluntsthedevelopmentofoffspringhypertensioninamaternaldi2ethylhexylphthalateexposureratmodel
AT houchihyao resveratrolbutyrateestersupplementationbluntsthedevelopmentofoffspringhypertensioninamaternaldi2ethylhexylphthalateexposureratmodel
AT changchienguoping resveratrolbutyrateestersupplementationbluntsthedevelopmentofoffspringhypertensioninamaternaldi2ethylhexylphthalateexposureratmodel
AT linsufan resveratrolbutyrateestersupplementationbluntsthedevelopmentofoffspringhypertensioninamaternaldi2ethylhexylphthalateexposureratmodel
AT hsuchienning resveratrolbutyrateestersupplementationbluntsthedevelopmentofoffspringhypertensioninamaternaldi2ethylhexylphthalateexposureratmodel